Cupid Ltd Q1 FY27 Results: Net Profit Soars 194% to ₹44 Crore

By Kaushik Brahmakshatriya

Published On 11 August 2026.

Cupid Ltd Q1 FY27 Results

Cupid Ltd Q1 FY27 Results have taken the market by surprise, with the healthcare and wellness products maker posting one of its strongest quarters ever. The company reported a massive jump in both revenue and profitability for the quarter ended June 30, 2026, driven by strong export demand and expanding domestic distribution. This blog breaks down the key numbers, growth drivers, and what lies ahead for the company in FY27.

Cupid Ltd Q1 FY27: Key Financial Performance Highlights

Cupid Limited delivered an exceptional performance in the first quarter of FY27. The company’s standalone net profit surged 194% year-on-year to ₹44.16 crore, compared to ₹15.02 crore in the same quarter last year. Revenue from operations climbed 159% to ₹154.72 crore, up from ₹59.80 crore in Q1 FY26. The EBITDA margin also improved sharply to 38.80%, reflecting stronger operating leverage and better cost efficiency across the business. This robust show places Cupid among the standout performers of the June 2026 quarter in the healthcare and personal care space.

Key Factors Driving Cupid Ltd’s Strong Q1 Performance

The strong Cupid Ltd Q1 FY27 Results were powered by several factors. The company’s international order book benefited from its multi-year South Africa condom supply contract, which continues to provide steady revenue visibility. On the domestic front, Cupid’s B2C wellness distribution expanded further, supported by its retail partnerships. Management also pointed to disciplined raw material planning, with the company holding close to 149 days of rubber inventory, which helped cushion margins against the recent surge in natural rubber prices. Institutional confidence also grew, with FII holding rising sharply to 4.17% during the quarter.

Cupid Ltd’s FY27Outlook and Future Guidance

Following this strong start, Cupid’s management raised its full-year FY27 revenue guidance by 10%, now targeting over ₹660 crore, up from the earlier ₹600 crore estimate. The company also announced plans to operationalise its new Palava manufacturing facility in the coming quarter, which is expected to further boost production capacity. The Board additionally approved an exploratory project in West Bengal for medical device manufacturing, signalling Cupid’s intent to diversify beyond its core contraceptive business into broader healthcare manufacturing.

FAQs Frequently Asked Questions

Q1. What was Cupid Ltd’s net profit in Q1 FY27?

Cupid Ltd reported a standalone net profit of ₹44.16 crore in Q1 FY27, up 194% year-on-year.

Q2. What is Cupid’s revenue guidance for FY27?

Cupid has raised its FY27 revenue guidance to over ₹660 crore, up from ₹600 crore earlier.

Q3. What drove Cupid’s strong Q1 FY27 performance?

Growth was driven by the South Africa contract, rising B2C wellness sales, and improved margins.

Conclusion

The Cupid Ltd Q1 FY27 Results highlight a company firmly on an upward growth trajectory, backed by strong export visibility, expanding domestic wellness sales, and improving margins. With raised guidance and new manufacturing capacity on the way, Cupid appears well positioned to sustain this momentum through the rest of FY27. Investors and industry watchers will likely track the Palava plant launch and West Bengal project closely in coming quarters.

Disclaimer :

This content is for informational and educational purposes only and is not investment advice. Please consult a financial advisor before making investment decisions